Lsv Asset Management Eli Lilly & CO Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $1.23 Million - $1.55 Million	-1,700 Reduced 5.3%	30,400 $27.5 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $8.05 Million - $10.8 Million	-13,600 Reduced 29.76%	32,100 $25 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $682,747 - $804,869	-1,300 Reduced 2.77%	45,700 $26.6 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $5.61 Million - $7.73 Million	-12,900 Reduced 21.54%	47,000 $25.2 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $6 Million - $8.02 Million	-17,100 Reduced 22.21%	59,900 $28.1 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $3.15 Million - $3.67 Million	-9,800 Reduced 11.29%	77,000 $28.2 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.46 Million - $2.89 Million	-8,829 Reduced 9.23%	86,800 $28.1 Million
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $306,935 - $397,018	-1,700 Reduced 1.75%	95,629 $21.9 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $279,344 - $361,624	-1,700 Reduced 1.72%	97,329 $18.2 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $652,300 - $863,150	-5,000 Reduced 4.81%	99,029 $16.7 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $518,395 - $623,884	3,800 Added 3.79%	104,029 $17.1 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $45.4 Million - $56.2 Million	-424,500 Reduced 80.9%	100,229 $13.2 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $24.2 Million - $26.3 Million	-226,400 Reduced 30.14%	524,729 $58.7 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $2.37 Million - $2.77 Million	-21,400 Reduced 2.77%	751,129 $83.2 Million
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $656,729 - $773,018	-5,900 Reduced 0.76%	772,529 $100 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $8.94 Million - $10 Million	-84,400 Reduced 9.78%	778,429 $90.1 Million
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $2.73 Million - $3.41 Million	-31,771 Reduced 3.55%	862,829 $92.6 Million
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $8.37 Million - $9.61 Million	110,600 Added 14.11%	894,600 $76.3 Million
Q1 2018 May 04, 2018	BUY	$74.21 - $87.6 $58.2 Million - $68.7 Million	784,000 New	784,000 $60.7 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account